Literature DB >> 6843824

Selective retrograde labelling of vestibular efferent neurons with [3H]choline.

D Demêmes, J Raymond, A Sans.   

Abstract

Following administration of [3H]choline in the lateral semicircular canal of the cat labyrinth, bidirectional axoplasmic transport [3H]choline and its derivatives was shown by radioautography in the vestibular system. Light-microscopic radioautographs exhibited various patterns of radioautographic labelling. First, a diffuse reaction was observed in vestibular nuclei representing anterograde-labelled, vestibular nerve endings. Second, a heavy labelling limited to perikarya was detected in efferent vestibular neurons and corresponded to retrograde transport. The anterograde migration of [3H]choline is known to be non-selective and is related to synthesis of phospholipids, non-diffusable molecules. In contrast, the retrograde perikaryal labelling seems highly selective and related to the cholinergic specificity of the transmitter. The selectivity of such labelling offers a further possibility of identifying cholinergic neurons and is additional evidence that cholinergic mechanisms are involved in the efferent vestibular control.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6843824     DOI: 10.1016/0306-4522(83)90066-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Identification of vestibular efferent neurons in the gerbil: histochemical and retrograde labelling.

Authors:  A A Perachio; G A Kevetter
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

2.  Some properties of frog vestibular choline acetyltransferase and acetylcholinesterase.

Authors:  I López; G Meza
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

3.  Origin of cochlea efferents in some gerbil species. A comparative anatomical study with fluorescent tracers.

Authors:  A Aschoff; M Müller; H Ott
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.